VIA
HAE icon

Virtus Investment Advisers’s Haemonetics HAE Stock Holding History

Virtus Investment Advisers’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-13,662
Closed -$1.13M – 353
2024
Q2 		$1.13M Hold
13,662
– – 0.96% 14
2024
Q1 		$1.17M Hold
13,662
– – 0.83% 21
2023
Q4 		$1.17M Hold
13,662
– – 0.87% 23
2023
Q3 		$1.22M Hold
13,662
– – 0.83% 30
2023
Q2 		$1.16M Hold
13,662
– – 0.79% 25
2023
Q1 		$1.13M Buy
13,662
+7,746
+131% +$627K 0.79% 30
2022
Q4 		$465K Hold
5,916
– – 0.31% 101
2022
Q3 		$438K Buy
+5,916
New +$425K 0.2% 99

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Virtus Investment Advisers's HAE Position: Q3 2024 in Review

Virtus Investment Advisers sold out of Haemonetics (HAE) in Q3 2024, closing a stake of 13,662 shares — an estimated $1.13M sold.

Virtus Investment Advisers first reported a position in HAE in Q3 2022 and held it in 8 quarters. The position peaked at $1.22M in Q3 2023. 306 funds tracked by Wall St. Rank hold HAE as of Q3 2024.

  • Virtus Investment Advisers reported no remaining Haemonetics position as of Q3 2024 after selling out during the quarter.
  • Virtus Investment Advisers sold 13,662 Haemonetics shares in Q3 2024, an estimated $1.13M.
  • Virtus Investment Advisers first reported a position in Haemonetics in Q3 2022 and held it in 8 quarters.
  • Virtus Investment Advisers's Haemonetics position peaked at $1.22M in Q3 2023.
  • 306 funds tracked by Wall St. Rank held Haemonetics as of Q3 2024.

Based on Virtus Investment Advisers's 13F filing for Q3 2024, filed 14 Nov 2024.